Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)
CUSIP: 19188J409
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 13,831,528
- Total 13F shares
- 738,638
- Share change
- -327,274
- Total reported value
- $1,468,069
- Price per share
- $1.99
- Number of holders
- 19
- Value change
- -$651,598
- Number of buys
- 6
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 19188J409?
CUSIP 19188J409 identifies COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 19188J409:
Top shareholders of COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
|
Company |
3%
|
420,710
|
$820,385 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
271,445
|
$529,318 | — | 31 Dec 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.82%
|
114,028
|
$222,000 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.54%
|
74,063
|
$144,423 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
69,534
|
$134,000 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.32%
|
44,694
|
$87,153 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.18%
|
24,443
|
$47,175 | — | 31 Dec 2022 | |
| Parallel Advisors, LLC |
13F
|
Company |
0.11%
|
15,228
|
$29,695 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
12,207
|
$23,804 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
8,991
|
$17,533 | — | 31 Dec 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.04%
|
4,847
|
$10,000 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
5,015
|
$9,779 | — | 31 Dec 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
260
|
$1,000 | — | 31 Dec 2022 | |
| Clean Yield Group |
13F
|
Company |
0%
|
418
|
$815 | — | 31 Dec 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
85
|
$166 | — | 31 Dec 2022 | |
| Archer Investment Corp |
13F
|
Company |
0%
|
84
|
$164 | — | 31 Dec 2022 | |
| NVWM, LLC |
13F
|
Company |
0%
|
84
|
$164 | — | 31 Dec 2022 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
18
|
$36 | — | 31 Dec 2022 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
18
|
$35 | — | 31 Dec 2022 |
Institutional Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) as of Q1 2023
As of 31 Mar 2023,
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
738,638 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, SABBY MANAGEMENT, LLC, MORGAN STANLEY, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Parallel Advisors, LLC, and NORTHERN TRUST CORP.
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
18
Q1 2023 holders
19
Holder diff
1
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.